Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients
NCT06915389
·
clinicaltrials.gov ↗
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Immunotherapy
Adverse Event
Metabonomics
Lipidomics
Sponsor
Qinghai Red Cross Hospital